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Abstract  
 
The critical importance of human milk to infants and even human civilization has been well 
established. Although the human milk microbiome has received increasing attention with the 
expansion of research on the human microbiome, our understanding of the milk microbiome has 
been limited to cataloguing OTUs and computation of community diversity indexes. To the best 
of our knowledge, there has been no report on the bacterial interactions within the human milk 
microbiome. To bridge this gap, we reconstructed a milk bacterial community network with the 
data from Hunt et al (2011)1, which is the largest 16S-rRNA sequence data set of human milk 
microbiome available to date. Our analysis revealed that the milk microbiome network consists 
of two disconnected sub-networks. One sub-network is a fully connected complete graph 
consisting of seven genera as nodes and all of its pair-wise interactions among the bacteria are 
facilitative or cooperative.  In contrast, the interactions in the other sub-network of 8 nodes are 
mixed but dominantly cooperative. Somewhat surprisingly, the only ‘non-cooperative’ nodes in 
the second sub-network are mutually cooperative Staphylococcus and Corynebacterium, genera 
that include some opportunistic pathogens. This potentially ‘evil’ alliance between 
Staphylococcus and Corynebacterium could be inhibited by the remaining nodes who cooperate 
with one another in the second sub-network. We postulate that the ‘confrontation’ between the 
‘evil’ alliance and ‘benign’ alliance in human milk microbiome should have important health 
implications to lactating women and their infants and shifting the balance between the two 
alliances may be responsible for dysbiosis of the milk microbiome that permits mastitis.  
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Introduction 
 
Human milk is generally considered the best source of nutrients for infants, and its health 
benefits such as prebiotics, immune proteins, and the microbiome of human milk itself, have 
been increasingly recognized1-5. Similar to other habitats in or on the human body such as the gut 
and skin, human milk is not sterile at all and it hosts extensive bacterial communities that are 
posited to possess important health implications. In general, traditional literature on human milk 
has been focused on pathogenic bacteria, and our understanding on commensal bacteria is still 
very limited in spite of the rapid advances in metagenomic technology and expanding studies of 
the human microbiome in recent years. For example, Heikkila & Saris (2003) investigated 
potential inhibition of Staphylococcus aureus by the commensal bacteria of breast milk6. 
Staphylococcus aureus is known as a food-poisoning agent and a common cause of infections 
including serious antibiotic-resistant hospital infections6,7. In addition it has been implicated in 
SIDS (Sudden Infant Death Syndrome) 8,9 as well as infectious mastitis that affects 20-30% 
lactating women6,10,11.  
 
There have been several studies that applied metagenomic sequencing technology to characterize 
human milk bacterial communities12-17 and a recent one by Hunt et al (2011) provides the largest 
data set of 16S rRNA sequences from human milk samples1. Hunt et al (2011) collected 47 
samples from 16 breastfeeding women (3 samples from all but one individual) who self-reported 
as healthy and between 20-40 yr of age1.  Their study revealed that the most abundant genera in 
the milk samples were Staphylococcus, Streptococcus, Serratia, and Corynebacteria, while eight 
other genera had relative abundances exceeding 1%. Besides characterizing the composition of 
milk bacterial community, Hunt et al. (2011) for the first time described the within-individual 
variation and the among-individuals variation of milk bacterial communities. The within-
individual variation, which can be thought as a measure of the stability of individual milk 
bacterial communities, differed between individuals. In other words, temporal variation of 
community membership or stability of individual milk communities varied significantly between 
women. For example, from the samples of “Subject #5,” Staphylococcus occupied either the first 
or second position in terms of the relative abundance (22-59%); but the samples of “Subject #1”, 
Staphylococcus only contributed less than 5% to the community abundance. The among-
individual variations in the relative abundances of bacteria were as large as six-fold1.  
 
Although milk microbiome was apparently missing in the initial US-NIH HMP roadmap, its 
critical importance to human health and diseases is evident. The importance is even more 
obvious from the perspective of its relationships with the microbiome in other body sites because 
human microbiome is location specific, but not isolated from one another at all5,18.  Zaura et al. 
(2014) hypothesized that development of fetal tolerance toward the microbiome of the mother 
during pregnancy is a major factor in the successful acquisition of a normal microbiome19.  
Jeurink et al. (2013) proposed a mechanism for the formation of breast milk micriobiome, which 
involves immune cell education by the pregnancy hormone progesterone leading to the 
transportation of bacteria from the mother to her mammal glands20. Guts of breastfed infants 
showed significantly higher counts of bifidobacteria and Lactobacillus and lower counts of 
Bacteroides, Clostridium coccoides group, Staphylococcus, and Enterobacteriaceae, as compared 
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with formula-fed infants21. The pioneering colonizers such as Bifidobacterium longum, which 
carries several gene clusters dedicated to the metabolism of human milk oligosaccharides 
(HMOs) allows infants to digest breast milk and possibly some simple vegetal food such as rice. 
González et al. (2013) found that women with HIV RNA in breast milk have a different pattern of 
microbial composition, compared with milk without HIV RNA, indicating specific 
immunological phenomena in HIV-infected women22. They also argued that breast milk and 
infant gut microbiota are essential for the maturation and protection of infant’s immune system. 
A metagenomic study conducted by Ward et al (2013) confirmed the benefits of breast milk 
ingestion to the microbial colonization of the infant gut and immunity4. The latter is 
demonstrated by the existence of immune-modulatory motifs in the metagenome of breast milk4. 
These recent studies exhibited the significant importance of breast milk microbiome in health 
and diseases.  
 
Obviously, Hunt et al (2011)1 and other previous culture-independent studies12-17,22-23 have 
deepened our understanding of bacterial communities in human breast milk. In a recent study, 
Guan and Ma (2014) applied Taylor’s power law and neutral theory to investigate the abundance 
distribution pattern and the maintenance mechanism of milk microbial community diversity, 
respectively by reanalyzing the existing data on milk microbiome24. The analysis with Taylor’s 
power law model indicated that bacterial population abundance in human milk microbiome is 
aggregated, rather than random, and it was found that neutral theory did not fit to any of the 47 
samples (communities), suggesting non-random interactions in community assembly and 
diversity maintenance24.  Nevertheless, due to the limitation of the analytical approaches used in 
previous studies, we still have little knowledge on the bacterial interactions, beyond their non-
random nature, within milk microbiome. Indeed, most statistical approaches are not powerful 
enough to reveal the interspecies interactions within a microbial community25, 26. In this article, 
we take advantage the power of network analysis in studying interspecies or inter-OTU 
(Operational Taxonomic Unit) interactions in a complex network setting such as a microbial 
community.  
 
Erdos and Renyi (1960)27 seminal research on random graph theory opened one of the most 
exciting new fields in combinatorial mathematics in the 20th century, and their random graph 
theory attracted extensive studies during the subsequent decades. Still, the avalanche of 
approaches to network analysis and the emergence of network science, of which random graph 
theory forms a theoretic foundation, was not triggered until the publication of two independent 
seminal papers published by Watts & Strogatz (1998) on the dynamics of “small-world” 
networks28 in the journal Nature, and by Barabási and Albert (1999) on the emergence of scaling 
(i.e., scale free networks) in random networks29 in the journal Science, respectively. A 
commonality of both the papers is the extension of basic random graph models so that they can 
better fit the patterns exhibited by many empirically observed networks in social, technological 
and natural networks. One of the most active application fields of network science is biology, 
thanks to the vast datasets available from genomic and metagenomic research. The case for 
applying network analysis to investigate the human microbiome was argued convincingly by 
Foster et al. (2008)30 and since then several network analyses have been successfully performed 
with human microbiome data31-33. One huge advantage of network analysis is its power to 
visualize multivariate relationships generated from big data sets such as genomic and 
metagenomic sequence data. Furthermore, various parameters computed with network analysis 
software packages (e.g., Cytoscape34, Gephi35) offer informative insights on the patterns in 
biological data. Complex network alignment algorithms and software (e.g., Graphcrunch236) can 
further be utilized to compare biological networks under different treatments.    
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Materials and Methods 
 
The 16S rRNA sequence data sets of human milk were collected by Hunt et al (2011)1. 
Specifically, the V1-V2 region of the bacterial 16S rRNA gene was amplified from genomic 
DNA using universal primers and approximately 300,000 reads were generated from the 
barcoded pyrosequencing of amplicons from 47 samples. After quality control, the data set was 
reduced to approximately 160,000 reads, with a mean of 3400 sequences per sample. The 
sequence data were assigned to the most likely bacterial genera using the RDP Bayesian 
classifier. A table of the 15 most abundant genera in each sample was supplied in the Supporting 
Information (Table S1) of Hunt et al (2011)1 and was used for our network analysis.  
 
 
Results and Discussion 
 
Results  
 
The pair-wise relationships among 15 genera were measured by Spearman rank correlation 
coefficients with p-value of 0.05, and the computed values of Spearman correlation coefficients 
with R-statistics package (www.r-project.org) were feed into Cytoscape network analysis 
software34 and Gephi35. The Graphcrunch236 software was applied to further compare the 
reconstructed milk microbiome network with several standard models of complex networks. The 
results are exhibited in the following Table 1 and Figure 1. 
 
 
Table 1. Topological properties of human milk bacterial network  
 
Number	  of	  
nodes	  
Number	  of	  edges	   Avg.	  number	  
of	  neighbors	  
Clustering	  
coefficient	  
Connected	  
components	  
Network	  
diameter	  
15 45 6 0.944 2 2 
Average	  path	  
length	  
Network	  density	   Modularity	   Number	  
of	  communities	  
Small-­‐world	  
networks	  
Scale-­‐free	  
network	  
1.082 0.429 0.498 2 Yes No 
 
 
 
、 
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Figure	  (1a)	   	   	   	   	   Figure	  (1b)	  
 
Figure	  (1c)     Figure	  (1d) 
 
Figure 1. Bacterial network of the human milk microbiome reconstructed using the data sets of 
Hunt et al. (2011): Figure (1a) and (1b) show the two disconnected sub-networks (components) 
of the breast milk bacterial network; Figure (1c) and (1d) are the same components, 
corresponding to (1a) and (1b), respectively, assuming the Staphylococcus and Corynebacterium 
nodes were eliminated. The green line represents a positive correlation (cooperative interaction) 
while the red line represents a negative correlation (non-cooperative interaction). Obviously, 
when the two mutually cooperative players Staphylococcus and Corynebacterium are removed, 
the whole network becomes totally cooperative (Figure 1c & 1d).  
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Before discussing our results further, it should be noted that like many other studies of biological 
networks, our network was built based on the correlation between OTUs. Our usage of 
terminology such as ‘cooperative’, ‘non-cooperative’, and ‘evil alliance’ are by analogy. 
Correlation is not equivalent with causation. For example, the correlation between two OTUs 
may be due to indirect ‘facilitation’ or ‘inhibition’ by a third player. Nevertheless, at this stage, 
correlation data are the only available data type for the human milk microbiome. The correlation 
network therefore offers the best apparatus available today to tackle the tangled microbiota in 
human milk. It should also be noted that the OTU data we used resolves taxa at the level of 
genera and a network based on species data may reveal different patterns from the networks we 
obtained. Hence, the total validity of the conclusions we draw below, ultimately, should be 
subject to testing in future biomedical research. Nevertheless, given the fundamental importance 
of studying milk microbiome, we believe that preliminary analyses such as this are warranted.    
 
From the above results in Figure 1 and Table 1, we draw the following conclusions:  
(i) The network of the breast milk bacterial community consists of two sub-networks, that 
correspond to two disconnected components or communities (Figure 1a, Figure 1b, and Table 1). 
One component (Figure 1b) consists of seven nodes in which all of the nodes are fully connected 
(forming a complete graph) and they interact cooperatively (positive correlations). Another 
component consists of 8 nodes and all of the interactions (edges) are cooperative except those 
that involve Staphylococcus and Corynebacterium. Therefore, if both Staphylococcus and 
Corynebacterium were removed, then the remaining nodes in the sub-network are fully 
cooperative.  Furthermore, the relationship between Staphylococcus and Corynebacterium are 
cooperative, although they do not cooperate with other taxa in the network. Obviously, the milk 
bacterial network is dominantly cooperative, and the ratio of cooperative vs. non-cooperative 
interactions is 4:1.    
  
As mentioned previously, Staphylococcus aureus is a food-poisoning agent and a common cause 
of infections including serious antibiotic-resistant hospital infections6,7, and the bacterium is also 
implicated in SIDS (Sudden Infant Death Syndrome)8,9 and infectious mastitis6,10,11. Mastitis is 
inflammation of the breast with or without infection, and Staphylococcus aureus has traditionally 
been believed to be the pathogen that is typically associated with infectious mastitis5.  There are 
studies that reveal some other species of Staphylococcus such as Staphylococcus epidermidis 
may play a prevalent role in mastitis infections2,5,37,38. Although the etiology of mastitis may vary 
there is evidence from animal studies and clinical trials that suggests certain strains of 
Lactobacillus can produce anti-inflammatory and anti-bacterial factors that inhibit adhesion and 
internalization of Staphylococcus spp. For example, Arroyo et al. (2010) reported that treatment 
with probiotic strains from human milk (containing Lactobacillus strains) produced a greater 
reduction in the bacterial counts of Staphylococcus epidermidis, Staphylococcus aureus and 
Staphylococcus mitis, as well as a greater reduction in pain than the treatment with antibiotics39.  
 
The genus Corynebacterium includes Gram-positive, rod-shaped bacteria that are largely 
innocuous and widely distributed in nature. However, some species such as C. diphtheriae may 
cause human disease. Extensive studies on the health implications of breast milk include 
protecting infants from diarrheal and respiratory diseases1,40,41. Our finding from network 
analysis that every other ‘player’ in the milk microbiome collectively ‘opposes’ or ‘inhibits’ 
Staphylococcus and Corynebacterium possibly explains the health effects of milk despite the 
presence of potential pathogens. In other words, from the perspective of a lactating mother and 
baby, it may be the cooperative and collective efforts of the other community members that 
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suppress the ‘evil’ alliance from opportunistically causing unhealthy consequences such as 
mastitis.   
 
(ii) The milk bacterial network is a ‘small-world’ network with a network diameter of only 2 and 
average minimal path length of p=1.082 (Table 1).  This is in accord with the criterion for 
judging small world networks28, in which  p=1.082<log(N)=log(15)=2.708. The criterion means 
that the typical distance p between two randomly chosen nodes grows proportionally to the 
logarithm of N, which is even smaller than the linear growth. In biological terms the interactions 
amongst the nodes (genera) are very tight.  
 
Nevertheless, the milk microbiome network is not scale-free, which is evidenced by the fact that 
the degree distribution of the network does not fit to a power law distribution (p-
value=0.323>0.05 from fitting power-law model, i.e., 
€ 
p(k)∝ k −λ ). A scale-free network has two 
properties: growth and preferential attachment29. Growth means that the number of nodes in the 
network increases over time and preferential attachment means that the more connected a node 
is, the more likely it is to receive new links. This absence of scale-free property may be due to 
the fact that our network is built with bacterial genera as the node units, which might be 
relatively constant over time and therefore the growth of nodes could be insignificant. We also 
utilized the network alignment software GraphCrunch236 to compare our milk microbiome 
network with 50 random instances of each of the following network models with the same size as 
microbiome network, respectively: ER (Erdos-Rényi random graphs), ER_DD (Erdos-Rényi 
random graphs with the same degree distribution as the data), GEO (Geometric Random 
Graphs), GEO-GD (Geometric Gene Duplication Models), SF (Scale-free Barabási-Albert 
Preferential Attachment Models), SF-GD (Scale-free Gene Duplication Models), and STICKY 
(Stickiness-index Based Models). The results from graphcrunch2 software also demonstrated 
that a scale-free network model was among the worst performing models. 
  
(iii) The other topological parameters of milk bacterial network shown in Table (1) also offer 
some interesting information about the network characteristics. Both the numbers of connected 
components and the number of communities in the network are two, corresponding to the two 
sub-networks (Figure 1a & 1b).  In general, the values of these two parameters are not 
necessarily equal, but their equality in the case of milk microbiome further strengthens the 
evidence that the milk microbiome network is divided into two separate sub-networks.  The high 
clustering coefficient of 0.944 signals the high aggregation tendency of network nodes. 
Moreover, a network density of 0.429 suggests that the number of edges in the network is about 
43%, i.e., less than half of all possible edges with a completely connected network (complete 
graph). Obviously, the lower density is because there is no edge (connection) between the two 
disconnected components, which significantly lowers the network density.  
 
 
Discussion  
 
In the study done by Hunt et al (2011)1 universal primers were used for amplification of the 16S 
rRNA gene, which increased sequencing coverage and helped them to obtain the most 
comprehensive experimental survey of milk microbiome to date.  Their study confirmed that 
Staphylococcus and Corynebacterium, identified here appear to exist as an “evil alliance” in the 
milk microbiome based on our network analysis even though they are typically present on adult 
skin too28. Hunt et al (2011) had recognized the possibility of contamination from the skin 
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microbiome and took extraordinary caution during sample collection. Furthermore, they 
compared the compositions of both milk and skin communities and concluded that bacterial 
communities in milk cannot simply be a result from skin contamination1. Some species of 
Staphylococcus and Corynebacteria are opportunistic infectious agents, and Staphylococcus 
aureus is associated with lactational mastitis. Other studies have also demonstrated the 
occurrence of Staphylococcus aureus in human milk1,22,42,43. It has been reported that, during the 
course of lactation, up to 30% of women suffer from breast infections or inflammation (mastitis) 
that often lead to fever, redness, swelling and breast pains44, 45. In Hunt et al (2011) study, the 
milk donors were self-reported as healthy, but at least one of the subjects showed symptoms of 
mastitis1. Therefore, at least, existing literature on milk microbiome referenced above indicates 
the existence of potentially opportunistic pathogens in milk of both healthy and diseased 
(mastitis) women. But why do those potential pathogens often seem harmless to lactating 
mothers and infants? In contrary, the existing literature documented the benefits of milk 
microbiome such as the protective effects of breastfeeding against diarrheal and respiratory 
disease as well as reduced risk of developing obesity in infants1. There is not an existing theory 
with sufficient evidence to explain the natural phenomenon in the existing literature of human 
milk microbiome.  
 
 A recent study by Urbaniak et al. (2014) investigated the existence of microbiome within 
mammary tissue by using 16S rRNA sequencing and culture46. They analyzed the breast tissue 
from 81 women with and without cancer in Canada and Ireland, and confirmed the existence of 
both health-conferring bacteria such as Lactobacillus and Bifidobacterium, as well as taxa known 
for pathogenesis such as Enterobacteriaceae, Pseudomonas, and Streptococcus agalactiae. Yet, 
none of the 81 women recruited had any clinical signs or symptoms of breast infection.  This 
echoes the phenomenon of the presence of opportunistic pathogens in breast milk revealed by 
our network analysis in this article.    
 
Our network analysis revealed the possible existence of an “evil alliance” between 
Staphylococcus and Corynebacterium, and this alliance is collectively ‘opposed’ or inhibited by 
the other members of breast milk bacterial community (network).  Our finding from network 
analysis therefore offers a piece of concrete evidence to support the following hypothesis: 
Similar to natural ecosystems, the ecosystem of human milk microbiome, which consists of the 
milk microbial community and its environment (i.e., the human body or host), contains microbial 
species of various characteristics or functions, being beneficial, harmful, or neutral from a human 
health perspective. This dynamic balance in the milk microbiome ecosystem depends on the 
species interactions within the microbiome bacterial community as well as the host environment 
such as immune system. The states of the milk microbiome (network), which could correspond 
to healthy or disease states of human body, depend on the interactions within the microbiome 
network (as exhibited by Figure 1) as well as the host, which may have her unique genomic, 
immunological, physiological and demographic properties. Specifically, we postulate that in 
healthy state, the adverse consequences of the “evil alliance” of Staphylococcus and/or 
Corynebacteria is ‘contained’ or inhibited by the collective cooperative defense of other 
community members. In the face of a disturbance of ‘evil alliance’ cannot be contained, and the 
balance may be disrupted or shifted to an alternative state, which may correspond to disease such 
as mastitis, whose underlying causes or triggers are not known yet.  In other words, the “evil 
alliance” of Staphylococcus and Corynebacterium are opportunistic and they cause disease to 
their host only if the collective containment by other members of the microbiome coupled with 
the defense of host immune system are weakened to such extent that their disturbance cannot be 
‘absorbed’ or tolerated. In a recent study, Ward et al. (2013) postulated that it might be the 
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diversity or genetic traits of the milk metagenome that confer benefits to infants, rather than the 
action of any one bacterial genus or species4. We argue that our hypothesis of dynamic balance 
of milk microbiome ecosystem is consistent with the ideas postulated by Ward et al. (2013)4 for 
the following two reasons: (i) the diversity and/or sequences of DNA within the metagenome 
referred by Ward et al. (2103)4 are carried by the microbiome, and they are the ‘surrogates’ of 
the species or OTUs within microbiome; (ii) ecological theory tells us, that diversity and 
stability, are tangled together, even if stability is not determined by diversity. Indeed, the 
diversity-stability paradigm debates have been going on for more than a half-century now, but 
nobody denies their close relationship. In fact, a recent consensus has been that network analysis 
should play a critical role in investigating the paradigm. We hope this relatively simple network 
analysis reported here will induce more extensive applications of network analysis approaches to 
the study of human milk microbiome, especially the stability (balance) of the milk ecosystem, 
which should greatly enhance our understanding of the health and disease implications of milk 
bacterial microbiota.  
 
There remain some important follow-up questions to this network analysis, and the answers will 
need efforts from the biomedical research community. Indeed, the insights from our network 
analysis should only be a starting point for thoroughly understanding the health and disease 
implications of the human milk microbiome. Experimental and clinical studies of human milk 
microbiome are crucial, but also understandably difficult to conduct. We realize that even the 
basic research of the species identification of human milk microbes is still at the very 
preliminary stage. Both our analysis and the study done by Hunt et al (2011)1, from which we 
obtained data for reconstructing the milk microbiome network, only reported the genera of 
bacteria present, but not the species within these genera. This data limitation strongly constrained 
our capability to infer further information on the bacterial interaction within human milk 
microbiome. Given the self-evident, critical importance of human milk microbiome, we hope 
this study will be a stepping stone for more advanced network analysis based on more 
comprehensive biomedical data sets generated by future studies of the human milk microbiome.  
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